Clinical Heart and Vascular Center
Physician Update 2020
New Patient Appointment or 214-645-8300
Every year at UT Southwestern we look forward to the exchange of ideas, presentations, and conclusions shared at the American Heart Association (AHA) Scientific Sessions.
This year’s virtual format did not diminish the quality and usefulness of the information that is always on display at the Sessions, nor did it materially impact another tradition at this annual gathering: the attendance of a sizeable number of UT Southwestern cardiologists, either presenting their research or moderating sessions.
We look forward to sharing our most relevant presentations indexed below for your convenience.
Articles & Presentations
HFpEF: Mechanism and Management
By Joseph A. Hill, M.D., Ph.D.
#AHA20 – A View from the Virtual Flight Deck
By Mark Drazner, M.D., M.Sc.
Impact of COVID-19 on National BP Trends
By Eric Peterson, M.D., M.P.H.
Using Electronic Health Record Data to Understand the COVID-19 Pandemic
By Ann Marie Navar, M.D., Ph.D.
The AHA COVID-19 Cardiovascular Disease Registry: A ‘Democratized’ Approach
By James de Lemos, M.D., and Sandeep Das, M.D., M.P.H.
Obesity and COVID-19: Evaluating the Risks
By Justin Grodin, M.D., M.P.H. and Nick Hendren, M.D.
COVID-19’s Lasting Impact on CV Disease Prevention
By Amit Khera, M.D., M.Sc.
High-Intensity Exercise for Patients with Hypertrophic Cardiomyopathy – Safe and Effective?
By Benjamin Levine, M.D.
Improving the Role of a Multidisciplinary Team in Transitions of Care
By Jennifer Thibodeau, M.D., M.S.C.S.
Hemodynamics and Congestion in Heart Failure: A Poster Session Review
By E. Ashley Hardin, M.D.
10-Year Risk of CHF in Blacks and Whites
By Ambarish Pandey, M.D., and Matthew Segar, M.D.
Novel Insights and Treatment of Duchenne Muscular Dystrophy-Associated Cardiomyopathy
By Pradeep P.A. Mammen, M.D.
Evaluating Outcomes of ACM Patients Implanted with Durable MCSDs
By Justin Grodin, M.D., M.P.H. and Katherine Michelis, M.D.
More Aggressive Blood Pressure Control Could Reduce HF, Mortality Risk
By Jarett Berry, M.D.
West African Genetic Ancestry and Blood Pressure Response in the SPRINT Trial
By Ambarish Pandey, M.D. and Shreya Rao, M.D.
E/e’ Does Not Consistently Track Left Atrial Pressure When Venous Return Is Altered in Individual Subjects
By James P. MacNamara, M.D. and Satyam Sarma, M.D.
On Managing Cardiac Sarcoidosis
By E. Ashley Hardin, M.D. and Vlad G. Zaha, M.D., Ph.D.
Arrhythmias in the Intensive Care Unit: Acute SVT Management
By Jose Joglar, M.D.
Cardio-Oncology: When Cancer and Cardiovascular Health Collide
By Vlad G. Zaha, M.D., Ph.D. and Anjali Rao, M.D.
Type 2 Diabetes and Heart Failure: Can We Break the Link?
By Ambarish Pandey, M.D.
Cardiology Fellow Dr. Glynnis Garry Wins AHA’s ‘Katz Prize’ – Making History
Explore Physician Update 2020:
- High-Intensity Exercise for Patients with Hypertrophic Cardiomyopathy – Safe and Effective?
- #AHA20 – A View from the Virtual Flight Deck
- HFpEF: Mechanism and Management
- Impact of COVID-19 on National BP Trends
- COVID-19’s Lasting Impact on CV Disease Prevention
- Improving the Role of a Multidisciplinary Team in Transitions of Care
- Hemodynamics and Congestion in Heart Failure: A Poster Session Review
- 10-Year Risk of CHF in Blacks and Whites
- Novel Insights and Treatment of Duchenne Muscular Dystrophy-Associated Cardiomyopathy
- Evaluating Outcomes of ACM Patients Implanted with Durable MCSDs
- More Aggressive Blood Pressure Control Could Reduce HF, Mortality Risk
- West African Genetic Ancestry and Blood Pressure Response in the SPRINT Trial
- On Managing Cardiac Sarcoidosis
- Arrhythmias in the Intensive Care Unit: Acute SVT Management
- Cardio-Oncology: When Cancer and Cardiovascular Health Collide
- Using Electronic Health Record Data to Understand the COVID-19 Pandemic
- Cardiology Fellow Dr. Glynnis Garry Wins AHA’s ‘Katz Prize’ – Making History
- E/e’ Does Not Consistently Track Left Atrial Pressure When Venous Return Is Altered in Individual Subjects
- Type 2 Diabetes and Heart Failure: Can We Break the Link?
- Obesity and COVID-19: Evaluating the Risks
- The AHA COVID-19 Cardiovascular Disease Registry: A ‘Democratized’ Approach